company background image
2755 logo

Beijing Aosaikang Pharmaceutical SZSE:002755 Stock Report

Last Price

CN¥11.13

Market Cap

CN¥10.0b

7D

0.3%

1Y

2.5%

Updated

21 May, 2024

Data

Company Financials

Beijing Aosaikang Pharmaceutical Co., Ltd.

SZSE:002755 Stock Report

Market Cap: CN¥10.0b

2755 Stock Overview

Beijing Aosaikang Pharmaceutical Co., Ltd.

2755 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rewards

Risk Analysis


Beijing Aosaikang Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beijing Aosaikang Pharmaceutical
Historical stock prices
Current Share PriceCN¥11.13
52 Week HighCN¥12.28
52 Week LowCN¥6.50
Beta0.37
1 Month Change30.33%
3 Month Change29.12%
1 Year Change2.49%
3 Year Change-17.92%
5 Year Change-13.25%
Change since IPO-13.11%

Recent News & Updates

Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues

May 21
Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues

Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?

Apr 29
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?

There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump

Mar 13
There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump

Recent updates

Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues

May 21
Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues

Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?

Apr 29
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?

There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump

Mar 13
There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump

Shareholder Returns

2755CN PharmaceuticalsCN Market
7D0.3%-1.6%1.1%
1Y2.5%-10.9%-10.2%

Return vs Industry: 002755 exceeded the CN Pharmaceuticals industry which returned -10.9% over the past year.

Return vs Market: 002755 exceeded the CN Market which returned -10.2% over the past year.

Price Volatility

Is 2755's price volatile compared to industry and market?
2755 volatility
2755 Average Weekly Movement8.3%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement7.2%
10% most volatile stocks in CN Market10.7%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 002755's share price has been volatile over the past 3 months.

Volatility Over Time: 002755's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20031,215Jingfei Mawww.ask-pharm.com

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in digestive, oncology, antibiotic, and other areas.

Beijing Aosaikang Pharmaceutical Co., Ltd. Fundamentals Summary

How do Beijing Aosaikang Pharmaceutical's earnings and revenue compare to its market cap?
2755 fundamental statistics
Market capCN¥10.01b
Earnings (TTM)-CN¥48.39m
Revenue (TTM)CN¥1.55b

6.7x

P/S Ratio

-213.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2755 income statement (TTM)
RevenueCN¥1.55b
Cost of RevenueCN¥292.87m
Gross ProfitCN¥1.26b
Other ExpensesCN¥1.31b
Earnings-CN¥48.39m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.052
Gross Margin81.15%
Net Profit Margin-3.12%
Debt/Equity Ratio2.9%

How did 2755 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.